Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

To achieve the objectives of the study, two different approaches were followed: (A) In vivo: To investigate, in a mouse model of mild Chronic Renal Failure (CRF) the efficacy of the vitamin D system in the prevention of aortic miR-145 reduction and its associated vascular injury. (B) Ex vivo and in vitro: To investigate in aortic rings and VSMC the potential links between the reduction in miR-145, osterix/Runx2-driven osteogenic differentiation and Ca deposition.

Source: 2.1. General Design of the Study. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

To achieve the objectives of the study, two different approaches were followed: (A) In vivo: To investigate, in a mouse model of mild Chronic Renal Failure (CRF) the efficacy of the vitamin D system in the prevention of aortic miR-145 reduction and its associated vascular injury.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia

Study design awaiting verification · Nutrients · 2022

Original publication title

Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia

Natalia Carrillo-López; Sara Panizo; Maria Vittoria Arcidiacono; Sandra de la Fuente; Laura Martínez-Arias; Emerenziana Ottaviano; Catalina Ulloa; María Piedad Ruiz-Torres; Isabel Rodríguez; Jorge B. Cannata-Andía; Manuel Naves-Díaz; Adriana S. Dusso

© 2022 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

In chronic kidney disease, systemic inflammation and high serum phosphate (P) promote the de-differentiation of vascular smooth muscle cells (VSMC) to osteoblast-like cells, increasing the propensity for medial calcification and cardiovascular mortality. Vascular microRNA-145 (miR-145) content is essential to maintain VSMC contractile phenotype. Because vitamin D induces aortic miR-145, uremia and high serum P reduce it and miR-145 directly targets osteogenic osterix in osteoblasts, this study evaluated a potential causal link between vascular miR-145 reductions and osterix-driven osteogenic differentiation and its counter-regulation by vitamin D.

Studies in aortic rings from normal rats and in the rat aortic VSMC line A7r5 exposed to calcifying conditions corroborated that miR-145 reductions were associated with decreases in contractile markers and increases in osteogenic differentiation and calcium (Ca) deposition. Furthermore, miR-145 silencing enhanced Ca deposition in A7r5 cells exposed to calcifying conditions, while miR-145 overexpression attenuated it, partly through increasing α-actin levels and reducing osterix-driven osteogenic differentiation. In mice, 14 weeks after the induction of renal mass reduction, both aortic miR-145 and α-actin mRNA decreased by 80% without significant elevations in osterix or Ca deposition.

Vitamin D treatment from week 8 to 14 fully prevented the reductions in aortic miR-145 and attenuated by 50% the decreases in α-actin, despite uremia-induced hyperphosphatemia. In conclusion, vitamin D was able to prevent the reductions in aortic miR-145 and α-actin content induced by uremia, reducing the alterations in vascular contractility and osteogenic differentiation despite hyperphosphatemia.

Authors’ abstract

In chronic kidney disease, systemic inflammation and high serum phosphate (P) promote the de-differentiation of vascular smooth muscle cells (VSMC) to osteoblast-like cells, increasing the propensity for medial calcification and cardiovascular mortality. Vascular microRNA-145 (miR-145) content is essential to maintain VSMC contractile phenotype. Because vitamin D induces aortic miR-145, uremia and high serum P reduce it and miR-145 directly targets osteogenic osterix in osteoblasts, this study evaluated a potential causal link between vascular miR-145 reductions and osterix-driven osteogenic differentiation and its counter-regulation by vitamin D.

Studies in aortic rings from normal rats and in the rat aortic VSMC line A7r5 exposed to calcifying conditions corroborated that miR-145 reductions were associated with decreases in contractile markers and increases in osteogenic differentiation and calcium (Ca) deposition. Furthermore, miR-145 silencing enhanced Ca deposition in A7r5 cells exposed to calcifying conditions, while miR-145 overexpression attenuated it, partly through increasing α-actin levels and reducing osterix-driven osteogenic differentiation. In mice, 14 weeks after the induction of renal mass reduction, both aortic miR-145 and α-actin mRNA decreased by 80% without significant elevations in osterix or Ca deposition.

Vitamin D treatment from week 8 to 14 fully prevented the reductions in aortic miR-145 and attenuated by 50% the decreases in α-actin, despite uremia-induced hyperphosphatemia. In conclusion, vitamin D was able to prevent the reductions in aortic miR-145 and α-actin content induced by uremia, reducing the alterations in vascular contractility and osteogenic differentiation despite hyperphosphatemia.

Publication and source details

Original title: Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia

Natalia Carrillo-López; Sara Panizo; Maria Vittoria Arcidiacono; Sandra de la Fuente; Laura Martínez-Arias; Emerenziana Ottaviano; Catalina Ulloa; María Piedad Ruiz-Torres; Isabel Rodríguez; Jorge B. Cannata-Andía; Manuel Naves-Díaz; Adriana S. Dusso

Nutrients · 2022

* Correspondence: jorge.cannata@gmail.com (J.B.C.-A.); adusso@wustl.edu (A.S.D.)
†

These authors contributed equally to this work.

‡

These authors contributed equally to this work.

§

These authors contributed equally to this work.

© 2022 by the authors.2022https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Instituto de Salud Carlos IIIFIS PI11/00259PI13/00497PI14/01452PI16/00637PI17/02181PI19/00532PI20/00753ISCIII Retic REDinRENRD16/0009/0017RICORS2040 (Kidney Disease)Fondo Europeo de Desarrollo Regional (FEDER), Plan de Ciencia, Tecnología e Innovación 2013 to 2017 y 2018 to 2022 del Principado de AsturiasGRUPIN14-028IDI-2018-000152IDI-2021-000080Fundación Renal Iñigo Álvarez de Toledo (FRIAT)Fundación para la Investigación Biosanitaria de Asturias (FINBA): Instituto de Investigación Sanitaria del Principado de Asturias (ISPA)Educational Grant from the ERA-EDTA CKD-MBD Working GroupAsociación Investigación de Fisiología AplicadaThe authors wish to thank the support of Instituto de Salud Carlos III (FIS PI11/00259, PI13/00497, PI14/01452, PI16/00637, PI17/02181, PI19/00532, PI20/00753), the ISCIII Retic REDinREN (RD16/0009/0017) and RICORS2040 (Kidney Disease), Fondo Europeo de Desarrollo Regional (FEDER), Plan de Ciencia, Tecnología e Innovación 2013 to 2017 y 2018 to 2022 del Principado de Asturias (GRUPIN14-028, IDI-2018-000152, IDI-2021-000080), Fundación Renal Iñigo Álvarez de Toledo (FRIAT). N.C.-L. was supported by IDI-2018-000152 and IDI-2021-000080, S.P. by IDI-2018-000152 and Fundación para la Investigación Biosanitaria de Asturias (FINBA): Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), M.V.A. was supported by Educational Grant from the ERA-EDTA CKD-MBD Working Group, L.M.-A. by ISCIII-FINBA (PI16/00637) and IDI-2021-000080, I.R. by FINBA, and A.S.D. by Asociación Investigación de Fisiología Aplicada.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T09:55:19.889127+00:00

DOI: 10.3390/nu14132589 · PMC9268464